Endo Int'l Reports Top-line Results From Phase 2 Study Of CCH For Adhesive Capsulitis Of Shoulder

RTTNews | 668 dagar sedan
Endo Int'l Reports Top-line Results From Phase 2 Study Of CCH For Adhesive Capsulitis Of Shoulder

(RTTNews) - Pharmaceutical company Endo International plc (ENDP) announced Friday top-line results from its Phase 2 study of Collagenase Clostridium Histolyticum (CCH) in participants with adhesive capsulitis (AC) of the shoulder, commonly known as "frozen shoulder."

The Phase 2 study participants receiving up to three doses of CCH showed some improvement in the change from baseline in the adapted American Shoulder and Elbow Surgeons (ASES) Standardized Shoulder Form composite score for the affected shoulder at the Day 95 visit.

The difference compared to those study participants receiving placebo was not statistically significant.

The safety profile of CCH in the Phase 2 study was consistent with the known safety profile from other studies.

The Phase 2 trial enrolled 198 participants with unilateral idiopathic AC of the shoulder with restricted range of motion (ROM) and function in the affected shoulder. Participants were randomized 1:1 to receive CCH or placebo administered by ultrasound-guided injection.

read more
Endo Intl's Par Pharma Recalls Treprostinil Injection For Silicone Particulates

Endo Intl's Par Pharma Recalls Treprostinil Injection For Silicone Particulates

Dublin, Ireland -based Endo International plc announced that its operating company Par Pharmaceutical, Inc. is recalling one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The recall, being conducted along with the U.S. Food and Drug Administration, is due to the potential for the presence of silicone particulates in the product solution.
RTTNews | 47 dagar sedan
Endo International Says Health Canada Approves XCOPRI To Treat Epilepsy

Endo International Says Health Canada Approves XCOPRI To Treat Epilepsy

Specialty pharmaceutical company Endo International plc (ENDPQ.PK) announced Thursday that its operating company Paladin Labs, Inc. (PLB.TO) has received Health Canada's approval of XCOPRI (cenobamate tablets) for adjunctive therapy in the management of partial-onset seizures in adults with epilepsy who are not satisfactorily controlled with conventional therapy.
RTTNews | 305 dagar sedan
Steady Start Set For Taiwan Stock Market

Steady Start Set For Taiwan Stock Market

The Taiwan stock market has tracked higher in consecutive trading days, accelerating almost 750 points or 3.8 percent along the way. The Taiwan Stock Exchange now sits just beneath the 20,500-point plateau and it may open higher again on Tuesday.
RTTNews | 4h 13minuter sedan
Japan Retail Sales Slip 1.2% On Month In March

Japan Retail Sales Slip 1.2% On Month In March

The value of retail sales in Japan was down a seasonally adjusted 1.2 percent on month in March, the Ministry of Economy, Trade and Industry said on Tuesday - coming in at 14.691 billion yen.
RTTNews | 4h 38minuter sedan
Singapore Stock Market May Open To The Upside

Singapore Stock Market May Open To The Upside

The Singapore stock market on Monday ended the two-day slide in which it had slipped almost 15 points or 0.5 percent. The Straits Times Index now rests just above the 3,280-point plateau and it may see additional support on Tuesday.
RTTNews | 4h 43minuter sedan
Japan Jobless Rate Holds Steady At 2.6%

Japan Jobless Rate Holds Steady At 2.6%

The unemployment rate in Japan was a seasonally adjusted 2.6 percent in March, the Ministry of Internal Affairs and Communications said on Tuesday.
RTTNews | 5h 3minuter sedan